Fuji Pharma Co.,Ltd. Logo

Fuji Pharma Co.,Ltd.

4554 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区三番町5番地7
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Fuji Pharma Co., Ltd. is a prominent Japanese pharmaceutical company dedicated to developing and manufacturing high-quality medications. With a strong emphasis on research and innovation, the company focuses on therapeutic areas such as infectious diseases, metabolic disorders, and oncology. Fuji Pharma is committed to enhancing global healthcare through its diverse portfolio of products, which includes both prescription and over-the-counter medications. The company adheres to stringent quality standards and regulatory compliance to ensure the safety and efficacy of its offerings. With a vision to improve patient outcomes, Fuji Pharma continues to invest in advanced technologies and collaborations, striving to meet the evolving needs of patients and healthcare professionals worldwide.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Fuji Pharma Co.,Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-09 04:10
Regulatory News Service
確認書
Japanese 8.7 KB
2025-05-09 04:09
Interim Report
半期報告書-第61期(2024/10/01-2025/09/30)
Japanese 216.6 KB
2024-12-23 04:46
Regulatory News Service
臨時報告書
Japanese 25.0 KB
2024-12-23 04:37
Regulatory News Service
確認書
Japanese 8.7 KB
2024-12-23 04:33
Regulatory News Service
内部統制報告書-第60期(2023/10/01-2024/09/30)
Japanese 23.3 KB
2024-12-23 04:32
Annual Report
有価証券報告書-第60期(2023/10/01-2024/09/30)
Japanese 1.7 MB
2024-07-18 09:11
Prospectus
有価証券届出書(参照方式)
Japanese 285.7 KB
2024-05-10 07:27
Quarterly Report
四半期報告書-第60期第2四半期(2024/01/01-2024/03/31)
Japanese 216.0 KB
2024-05-10 07:27
Regulatory News Service
確認書
Japanese 8.6 KB
2024-02-09 08:20
Regulatory News Service
確認書
Japanese 8.7 KB
2024-02-09 08:19
Quarterly Report
四半期報告書-第60期第1四半期(2023/10/01-2023/12/31)
Japanese 178.7 KB
2023-12-21 07:28
Regulatory News Service
臨時報告書
Japanese 27.9 KB
2023-12-21 07:26
Regulatory News Service
確認書
Japanese 8.7 KB
2023-12-21 07:25
Regulatory News Service
内部統制報告書-第59期(2022/10/01-2023/09/30)
Japanese 23.3 KB
2023-12-21 07:23
Annual Report
有価証券報告書-第59期(2022/10/01-2023/09/30)
Japanese 1.6 MB

Automate Your Workflow. Get a real-time feed of all Fuji Pharma Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Fuji Pharma Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK